Bioavailability of a drug is largely determined by the properties of the dosage form, which depend partly on its design and manufacture. Differences in bioavailability among formulations of a given drug can have clinical significance; thus, knowing whether drug formulations are equivalent is essential. Bioequivalent products are expected to be therapeutically equivalent. Therapeutic nonequivalence (eg, more adverse effects, less efficacy) is usually discovered during long-term treatment when patients who are stabilized on one formulation
2021 Conference Announcement: Alternative & Integrative Medicine
2021 Conference Announcement: Alternative & Integrative Medicine
Short Communication: Cancer Science & Therapy
Short Communication: Cancer Science & Therapy
Case Report: Pulmonary & Respiratory Medicine
Case Report: Pulmonary & Respiratory Medicine
Editorial: Nuclear Medicine & Radiation Therapy
Editorial: Nuclear Medicine & Radiation Therapy
Review Article: Journal of Sports Medicine & Doping Studies
Review Article: Journal of Sports Medicine & Doping Studies
Posters & Accepted Abstracts: Cardiovascular Diseases & Diagnosis
Posters & Accepted Abstracts: Cardiovascular Diseases & Diagnosis
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Posters-Accepted Abstracts: Cancer Science & Therapy
Posters-Accepted Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Journal of Health & Medical Informatics
Scientific Tracks Abstracts: Journal of Health & Medical Informatics
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Scientific Tracks Abstracts: Journal of Nephrology & Therapeutics
Journal of Surgical Pathology and Diagnosis received 15 citations as per Google Scholar report